Child, Hospitalized
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Robot Rehab: AAI With Robot During Inpatient Pediatric Rehab
Pharmacological and Non-pharmacological Interventions in Management of Venipuncture Pain.
A Study to Learn About the Medicine Called Nirmatrelvir Used in Combination With Ritonavir in People With Weakened Immune Systems or at Increased Risk for Poor Outcomes Who Are Hospitalized Due to Severe COVID-19
Effect of Vitamin D Supplementation on Improvement of Pneumonic Children
Family-Centered Rounds Checklist Implementation
Pain Management in Pediatric Intensive Care by Studying the Autonomic Balance
The Impact of Starbright World on Children Being Treated at the NIH